A Phase 1 Study Evaluating Safety Tolerability and Pharmacokinetics of Escalating Doses of AGS62P1 Given as Monotherapy in Subjects with Acute Myeloid Leukemia (AML)
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
